✦ LIBER ✦

Intravenous immune globulin therapy of immune deficiency disorders

✍ Scribed by Schwartz, Stanley A.

Book ID: 122536558
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 362 KB
Volume: 11
Category: Article
ISSN: 0197-1859
DOI: 10.1016/0197-1859(91)90011-G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous immune globulin in patients

Intravenous immune globulin in patients with acquired immune deficiency syndrome

✍ PAHWA, S 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 750 KB

Hemolysis following intravenous immune g

Hemolysis following intravenous immune globulin therapy

✍ E. A. Copelan; P. L. Strohm; M. S. Kennedy; P. J. Tutschka 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Intravenous immune globulin therapy: Mec

Intravenous immune globulin therapy: Mechanisms of action

✍ Fleisher, Thomas A. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Intravenous γ-globulin therapy in immune

Intravenous γ-globulin therapy in immune thrombocytopenia

✍ Michael Kaplan; Ayala Abramov; Avner Goren 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Intravenous immune globulin therapy: Cur

Intravenous immune globulin therapy: Current clinical applications

✍ Engler, Renata J.M.; Birx, Deborah L. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 155 KB

The cost of treating immune thrombocytop

The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin

✍ Sandler, S. Gerald; Novak, Sharon C.; Roland, Barbara 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 18 KB 👁 2 views

Multiple factors, including efficacy, toxicity and cost, may influence the decision to treat immune thrombocytopenic purpura (ITP) with intravenous immune globulin (IVIG) or intravenous Rho (D) immune globulin (IV RhIG). We conducted a survey of 50 hospitals in 31 states to determine the costs for t